RNA-Based Therapy Brings New Hope for an Incurable Blood Cancer

[Overstressed]

RNA-Based Therapy Brings New Hope for an Incurable Blood Cancer

ScienceDaily (Oct. 10, 2012) — Three thousand new cases of Mantle Cell Lymphoma (MCL), a form of blood cancer, appear in the United States each year. With a median survival span of only five to seven years, according to the Leukemia and Lymphoma Society, this disease is devastating, and new therapies are sorely needed.

Please find the article here;

http://www.sciencedaily.com/releases/2012/10/121010131546.htm

Overstressed: Another path to correct over-production of B-lymphocytes?​

Best wishes,
OS.
​